Moneycontrol

You are Here : API facility to boost revenue by 5-10%: Nectar Lifesciences

Friday, 02:29

Nectar Lifesciences has received European approval for its Cephalosporin APIs manufacturing facility at Derabassi in Punjab. Dinesh Dua, chief executive director at Nectar Lifesciences, in an interview to CNBC-TV18, said the API manufacturing facility is likely to boost the companys revenues by 5-10%.
APR 26, 2017
03:23 PM

cnbc tv18 shows

Search
All Shows
Go

NOW PLAYING

NSE Closing Bell

NSE Closing Bell kicks off as the market starts to shut shop. AnchorsSenthil Chengalvarayan and Menaka Doshihave it all covered for you - expert closing strategies at the start of the hour, the top 6 stocks in 60 seconds, broader markets decoded on Midcap Minute, update on the derivatives space wi ... more »

mytv on mobile

Track your portfolio on the go with

moneycontrol app

Sections
Follow us on
Available On